Apogee Therapeutics
(NASDAQ) APGE
Apogee Therapeutics Financials at a Glance
Market Cap
$10.02B
Revenue (TTM)
$0.00
Net Income (TTM)
-$274.62M
EPS (TTM)
-$4.33
P/E Ratio
-30.70
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$132.80
Volume
131,290
Open
$132.95
Price
$132.80
Volume
131,290
Open
$132.95
Previous Close
$132.88
Daily Range
$132.75 - $133.00
52-Week Range
$34.34 - $133.16
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$132.80
Volume
131,290
Open
$132.95
Previous Close
$132.88
Daily Range
$132.75 - $133.00
52-Week Range
$34.34 - $133.16
Estimated Earnings Date
Aug 10, 2026
APGE News
APGE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Apogee Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
261
CEO
Michael Henderson, MD
Website
www.apogeetherapeutics.comHeadquarters
Waltham, MA 02453, US
APGE Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-32.64%
Return on Capital
-31.29%
Return on Assets
-21.23%
Earnings Yield
-3.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.02B
Shares Outstanding
75.39M
Volume
131.29K
Avg. Volume
2.06M
Financials (TTM)
Gross Profit
-$408.00K
Operating Income
-$305.27M
EBITDA
-$272.73M
Operating Cash Flow
-$234.54M
Capital Expenditure
-$830.00K
Free Cash Flow
-$235.37M
Cash & ST Invst.
$1.06B
Total Debt
$8.05M
Apogee Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$408.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$10.02B
N/A
Market Cap/Employee
$51.11M
N/A
Employees
196
N/A
Net Income
-$74.11M
-33.9%
EBITDA
-$73.62M
-33.7%
Quarterly Fundamentals
Total Cash
$1.06B
+106.5%
Total Debt
$8.05M
-31.9%
Accounts Receivable
$7.28M
+45.3%
Inventory
$0.00
N/A
Long Term Debt
$4.91M
-37.4%
Short Term Debt
$3.14M
-21.1%
Return on Assets
-21.23%
N/A
Return on Invested Capital
-24.21%
N/A
Free Cash Flow
-$55.57M
-5.3%
Operating Cash Flow
-$55.57M
-14.6%